[go: up one dir, main page]

AU7053000A - Flint compounds and formulations thereof - Google Patents

Flint compounds and formulations thereof

Info

Publication number
AU7053000A
AU7053000A AU70530/00A AU7053000A AU7053000A AU 7053000 A AU7053000 A AU 7053000A AU 70530/00 A AU70530/00 A AU 70530/00A AU 7053000 A AU7053000 A AU 7053000A AU 7053000 A AU7053000 A AU 7053000A
Authority
AU
Australia
Prior art keywords
flint
formulations
compounds
flint compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70530/00A
Inventor
Paul Robert Atkinson
Yu Tian
Derrick Ryan Witcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU7053000A publication Critical patent/AU7053000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU70530/00A 1999-09-10 2000-08-31 Flint compounds and formulations thereof Abandoned AU7053000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15344599P 1999-09-10 1999-09-10
US60153445 1999-09-10
PCT/US2000/020805 WO2001018041A2 (en) 1999-09-10 2000-08-31 Flint proteins and formulations thereof

Publications (1)

Publication Number Publication Date
AU7053000A true AU7053000A (en) 2001-04-10

Family

ID=22547253

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70530/00A Abandoned AU7053000A (en) 1999-09-10 2000-08-31 Flint compounds and formulations thereof

Country Status (2)

Country Link
AU (1) AU7053000A (en)
WO (1) WO2001018041A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
EP2311956A1 (en) 1999-06-28 2011-04-20 Genentech, Inc. Methods for making APO-2 ligand using divalent metal ions
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000070174A (en) * 1997-01-14 2000-11-25 벤슨 로버트 에이치. Tumor necrosis factor receptors 6α and 6β
US5885800A (en) * 1997-02-04 1999-03-23 Smithkline Beecham Corporation DNA encoding tumor necrosis related receptor, TR4
DK1015587T3 (en) * 1997-09-18 2008-08-25 Genentech Inc DcR3 polypeptide, a TNFR homolog
IL138626A0 (en) * 1998-03-30 2001-10-31 Lilly Co Eli Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily

Also Published As

Publication number Publication date
WO2001018041A3 (en) 2001-06-14
WO2001018041A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU6310000A (en) Aerosol formulations
AUPQ419099A0 (en) Novel compositions and methods
AU4943200A (en) Modified cytokine
AU4021100A (en) Novel formulations comprising lipid-regulating agents
AU3731600A (en) Composition and structures made therefrom
AU4017500A (en) Novel formulations comprising lipid-regulating agents
AU3215500A (en) Compounds and methods
AU7989400A (en) Compounds and methods
AUPQ441699A0 (en) Pour-on formulations
AU1887401A (en) Medicinal composition
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU1403501A (en) Novel composition and use
AUPQ342599A0 (en) Conjugates and uses thereof
AUPQ147699A0 (en) Sunscreen formulations
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7816000A (en) Pediculocidal and veterinary compositions
AU1152601A (en) Compositions and their use
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU4543500A (en) Pharmaceutical compositions and uses
AU4432001A (en) Trityl-type compounds and their use
AU6891800A (en) Flint analog compounds and formulations thereof
AU7053000A (en) Flint compounds and formulations thereof
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2669201A (en) Taccalonolides and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase